top banner imagetop banner mobile image

Press Releases

Date Title
11/12/19
Summary ToggleTherapeuticsMD Announces Participation at the Stifel 2019 Healthcare Conference
11/06/19
Summary ToggleTherapeuticsMD Announces Third Quarter 2019 Financial Results
11/01/19
Summary ToggleTherapeuticsMD to Report Third Quarter 2019 Results on November 6, 2019
10/30/19
Summary ToggleKnight and TherapeuticsMD Announce Filing of New Drug Submission for Joyesta™ in Canada
10/29/19
Summary ToggleTherapeuticsMD Announces Closing of Its Underwritten Public Offering of Common Stock
10/24/19
Summary ToggleTherapeuticsMD Announces Pricing of Its Underwritten Public Offering of 26 Million Shares of Common Stock
10/23/19
Summary ToggleTherapeuticsMD Announces Proposed Underwritten Public Offering of 22 Million Shares of Common Stock
10/23/19
Summary ToggleTherapeuticsMD Announces Estimated Third Quarter 2019 Financial Results
10/11/19
Summary ToggleTherapeuticsMD Announces Presentations on ANNOVERA™ at the 2019 Annual Meeting of the American Society for Reproductive Medicine
10/10/19
Summary ToggleTherapeuticsMD Vice President of Business Development Named Finalist in 16th Annual Stevie® Awards for Women in Business
09/26/19
Summary ToggleTherapeuticsMD Announces Participation at the 2019 Cantor Healthcare Conference
09/24/19
Summary ToggleTherapeuticsMD Announces Multiple Presentations Related to IMVEXXY® and BIJUVA® at the 2019 Annual Meeting of the North American Menopause Society
08/06/19
Summary ToggleTherapeuticsMD Announces Second Quarter 2019 Financial Results
07/25/19
Summary ToggleTherapeuticsMD to Report Second Quarter 2019 Results on August 6, 2019
06/10/19
Summary ToggleTherapeuticsMD to Host Investor and Analyst Day Today
06/07/19
Summary ToggleTherapeuticsMD and Theramex Enter into Exclusive License and Supply Agreement to Commercialize BIJUVA™ and IMVEXXY® Outside the United States
05/29/19
Summary ToggleTherapeuticsMD to Host Investor and Analyst Day on June 10, 2019 in New York City
05/08/19
Summary ToggleTherapeuticsMD Announces Participation at the Bank of America Merrill Lynch 2019 Health Care Conference
05/06/19
Summary ToggleTherapeuticsMD Announces First Quarter 2019 Financial Results
05/06/19
Summary ToggleTherapeuticsMD Presented New Research at the American College of Obstetricians and Gynecologists 2019 Annual Meeting that Explores How Women’s Menopausal Symptoms Affect Men
05/03/19
Summary ToggleTherapeuticsMD Announces Oral and Poster Presentations on BIJUVA™ and ANNOVERA™ at the American College of Obstetricians and Gynecologists 2019 Annual Meeting
04/29/19
Summary ToggleTherapeuticsMD to Report First Quarter 2019 Results on May 6, 2019
04/24/19
Summary ToggleTherapeuticsMD Closes $300 Million Non-Dilutive Term Loan Financing Facility with TPG Sixth Street Partners
04/17/19
Summary ToggleTherapeuticsMD Signs Binding Commitment Letter for $300 Million Non-Dilutive Term Loan Financing Facility with TPG Sixth Street Partners
04/17/19
Summary ToggleTherapeuticsMD Announces Commercial Availability of BIJUVA™ in the U.S.
03/25/19
Summary ToggleTherapeuticsMD Announces Oral and Poster Presentations on BIJUVA™ and ANNOVERA™ at the Endocrine Society 2019 Annual Meeting
03/08/19
Summary ToggleTherapeuticsMD Announces Oral Presentations on BIJUVA and ANNOVERA, and Poster Presentations Related to Menopause Symptoms and Treatments at 2019 ISSWSH/ISSM Joint Meeting
02/28/19
Summary ToggleTherapeuticsMD Announces Participation in Two Upcoming Investor Conferences
02/21/19
Summary ToggleTherapeuticsMD Announces Fourth Quarter and Full-Year 2018 Financial Results
02/08/19
Summary ToggleTherapeuticsMD to Report Fourth Quarter and Full Year 2018 Results on February 21, 2019
01/03/19
Summary ToggleTherapeuticsMD Announces Participation at 37th Annual J.P. Morgan Healthcare Conference